- 全部删除
您的购物车当前为空
Iptacopan hydrochloride (LNP023 hydrochloride) 是一种可口服、高效和高选择性的因子 B 抑制剂,IC50 为 10 nM。 LNP023 显示与人因子 B 的直接、可逆和高亲和力结合,KD 为 7.9 nM。

Iptacopan hydrochloride (LNP023 hydrochloride) 是一种可口服、高效和高选择性的因子 B 抑制剂,IC50 为 10 nM。 LNP023 显示与人因子 B 的直接、可逆和高亲和力结合,KD 为 7.9 nM。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 993 | In stock | |
| 5 mg | ¥ 2,320 | In stock | |
| 10 mg | ¥ 3,730 | In stock | |
| 25 mg | ¥ 5,930 | In stock | |
| 50 mg | ¥ 7,850 | In stock | |
| 100 mg | ¥ 10,800 | In stock | |
| 200 mg | ¥ 14,500 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,330 | In stock |
Iptacopan hydrochloride 相关产品
| 产品描述 | Iptacopan hydrochloride (LNP023 hydrochloride) is an orally bioavailable, highly potent and highly selective factor B inhibitor with an IC50 of 10 nM. Iptacopan hydrochloride shows direct, reversible, and high-affinity binding to human factor B with a KD of 7.9 nM. |
| 靶点活性 | FB:10 nM, FB:7.9 nM (KD), Membrane aTT cellsack Complex (MAC):130 nM |
| 体外活性 | LNP023在41种人类蛋白酶(包括AP蛋白因子D,>100 μM)的一系列测试中展现了对其他蛋白酶的极高选择性,其IC50值均>30 μM。 |
| 体内活性 | Iptacopan(20-180 mg/kg;口服)在大鼠膜性肾病实验模型中具有预防和治疗效果,并能防止小鼠KRN(150 μL)引发的关节炎[2]。口服后(大鼠30 mg/kg,犬10 mg/kg),Iptacopan在Wistar Han大鼠(半衰期3.4小时)和比格犬(半衰期5.5小时)体内展现中等半衰期(T1/2)和Cmax(Wistar Han大鼠410 nM,比格犬2200 nM)[3]。 |
| 别名 | LNP023 hydrochloride, Iptacopan HCl |
| 分子量 | 458.98 |
| 分子式 | C25H31ClN2O4 |
| CAS No. | 1646321-63-2 |
| Smiles | Cl.CCO[C@H]1CCN(Cc2c(OC)cc(C)c3[nH]ccc23)[C@@H](C1)c1ccc(cc1)C(O)=O |
| 密度 | no data available |
| 颜色 | Gray |
| 物理性状 | Solid |
| 存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | H2O: 50 mg/mL (108.94 mM), Sonication and heating are recommended. DMSO: 252 mg/mL (549.04 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
H2O/DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容